Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

"PharmaPoint: HIV - Current and Future Players" is now available at Fast Market Research


Print article Print article
2013-03-16 11:26:44 - New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

GlobalData has released its pharma report, "PharmaPoint: HIV - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HIV Market. The report identifies and analyses the key companies shaping and driving the global HIV market. The report provides insight into the competitive HIV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

* Investigation of current and future market competition for HIV
* Competitor assessment
* Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
* Strategic

assessment of the HIV sector through market impact analysis, future market scenario and company analysis

Reasons to buy

* Gain a high level view of the trends shaping and driving the HIV Market
* Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
* Create an effective counter-strategy to gain a competitive advantage against those currently in the market
* What's the next big thing in the global HIV market landscape? Identify, understand and capitalize


Full Report Details at
- www.fastmr.com/prod/553300_pharmapoint_hiv_current_and_future_pl ..


Companies Mentioned in this Report: Gilead, ViiV Healthcare, AbbVie (Abbott), Merck, Janssen (a Subsidiary of J&J), Bristol-Myers Squibb, Japan Tocacco

Report Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Market Outlook
3.1 Global Markets
3.1.1 Forecast
3.1.2 Drivers and Barriers - Global Issues
4 Current and Future Players
4.1 Overview
4.2 Trends in Corporate Strategy
4.3 Company Profiles
4.3.1 Gilead
4.3.2 ViiV Healthcare
4.3.3 AbbVie (Abbott)
4.3.4 Merck
4.3.5 Janssen (a Subsidiary of J&J)
4.3.6 Bristol-Myers Squibb
4.3.7 Japan Tocacco
5 Appendix
5.1 Bibliography
5.2 Abbreviations
5.3 Methodology
5.4 Forecasting Methodology
5.4.1 HIV Prevalence
5.4.2 Percent Drug-Treated Patients
5.4.3 Drugs Included in Each Therapeutic Class
5.4.4 Launch and Patent Expiry Dates
5.4.5 General Pricing Assumptions
5.4.6 Individual Drug Assumptions
5.4.7 Generic Erosion
5.4.8 Pricing of Pipeline agents
5.5 Physicians and Specialists Included in this Study
5.5.1 Survery of Prescribing Physicians
5.6 About the Authors
5.6.1 Authors
5.6.2 Epidemiologists
5.6.3 Global Head of Healthcare
5.7 About GlobalData
5.8 Contact Us
5.9 Disclaimer

List of Tables

1.1 List of Tables
Table 1: Global Sales Forecasts ($m) for HIV, 2012-2022
Table 2: Global HIV Market - Drivers and Barriers, 2012-2022
Table 3: Key Companies in the HIV Market, 2012
Table 4: Gilead's HIV Therapy Portfolio Assessment, 2012
Table 5: Gilead SWOT Analysis, 2012
Table 6: ViiV Healthcare's HIV Therapy Portfolio Assessment, 2012
Table 7: ViiV Healthcare SWOT Analysis, 2012
Table 8: AbbVie's HIV Therapy Portfolio Assessment, 2012
Table 9: AbbVie SWOT Analysis, 2012
Table 10: Merck's HIV Therapy Portfolio Assessment, 2012
Table 11: Merck SWOT Analysis, 2012
Table 12: Janssen's HIV Therapy Portfolio Assessment, 2012
Table 13: Janssen SWOT Analysis, 2012
Table 14: BMS' HIV Therapy Portfolio Assessment, 2012
Table 15: BMS SWOT Analysis, 2012
Table 16: Japan Tobacco's HIV Therapy Portfolio Assessment, 2012
Table 17: Japan Tobacco SWOT Analysis, 2012
Table 18: Key Launch Dates
Table 19: Key Patent Expiries
Table 20: Physicians Surveyed, By Country

List of Figures

1.2 List of Figures
Figure 1: Global Sales for HIV by Region, 2012-2022
Figure 2: Company Portfolio Gap Analysis in HIV, 2012-2022

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser